These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 10843747
41. Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma. Chodorowska G, Czelej D. Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):43-7. PubMed ID: 15314957 [Abstract] [Full Text] [Related]
42. Both serum receptors of tumor necrosis factor are influenced by mud pack treatment in osteoarthrotic patients. Bellometti S, Galzigna L, Richelmi P, Gregotti C, Bertè F. Int J Tissue React; 2002; 24(2):57-64. PubMed ID: 12182234 [Abstract] [Full Text] [Related]
43. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma. Czelej D, Chodorowska G, Lechowska-Mazur I. Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):38-42. PubMed ID: 15314956 [Abstract] [Full Text] [Related]
44. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, Szuba MP, Van Dongen HP, Dinges DF. J Allergy Clin Immunol; 2001 Jan; 107(1):165-70. PubMed ID: 11150007 [Abstract] [Full Text] [Related]
45. Dietary fat intake and proinflammatory cytokine levels in patients with heart failure. Lennie TA, Chung ML, Habash DL, Moser DK. J Card Fail; 2005 Oct; 11(8):613-8. PubMed ID: 16230265 [Abstract] [Full Text] [Related]
46. Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab. Di Rocco P, Manco M, Rosa G, Greco AV, Mingrone G. Obes Res; 2004 Apr; 12(4):734-9. PubMed ID: 15090644 [Abstract] [Full Text] [Related]
47. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease]. Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, Janowska J, Szulc A, Jastrzebska-Maj E, Szymański L. Pol Merkur Lekarski; 2001 Jul; 11(61):19-25. PubMed ID: 11579824 [Abstract] [Full Text] [Related]
48. Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils. Xing L, Remick DG. Shock; 2003 Jul; 20(1):10-6. PubMed ID: 12813362 [Abstract] [Full Text] [Related]
49. A 7-day oral treatment of patients with active rheumatoid arthritis using the prostacyclin analog iloprost: cytokine modulation, safety, and clinical effects. Gao IK, Scholz P, Boehme MW, Norden C, Lemmel EM. Rheumatol Int; 2002 Jun; 22(2):45-51. PubMed ID: 12070674 [Abstract] [Full Text] [Related]
50. Is there a correlation between tumor necrosis factor alpha and soluble p-55 receptor plasma levels in advanced gastrointestinal cancer patients? Muc-Wierzgoń M, Madej K, Baranowski M, Wierzgoń J. J Biol Regul Homeost Agents; 1996 Jun; 10(4):95-7. PubMed ID: 9604778 [Abstract] [Full Text] [Related]
51. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis. Muzaffer MA, Dayer JM, Feldman BM, Pruzanski W, Roux-Lombard P, Schneider R, Laxer RM, Silverman ED. J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325 [Abstract] [Full Text] [Related]
52. Ultrafiltration after cardiopulmonary bypass in children: effects on hemodynamics, cytokines and complement. Saatvedt K, Lindberg H, Geiran OR, Michelsen S, Pedersen T, Seem E, Mollnes TE. Cardiovasc Res; 1996 Apr; 31(4):596-602. PubMed ID: 8689651 [Abstract] [Full Text] [Related]
53. Circadian rhythm of the soluble p75 tumor necrosis factor (sTNF-R75) receptor in humans--a possible explanation for the circadian kinetics of TNR-alpha effects. Liebmann PM, Reibnegger G, Lehofer M, Moser M, Pürstner P, Mangge H, Schauenstein K. Int Immunol; 1998 Sep; 10(9):1393-6. PubMed ID: 9786439 [Abstract] [Full Text] [Related]
54. [Cytokine networks and their endogenous modulators in patients with congestive heart failure]. Yang L, Zhu S, Wang X. Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):660-2. PubMed ID: 11769717 [Abstract] [Full Text] [Related]
55. Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Petrovsky N, McNair P, Harrison LC. Cytokine; 1998 Apr; 10(4):307-12. PubMed ID: 9617577 [Abstract] [Full Text] [Related]
56. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Lew R, Innis BL, Kurane I, Rothman AL, Ennis FA. J Infect Dis; 1999 Apr; 179(4):755-62. PubMed ID: 10068569 [Abstract] [Full Text] [Related]
57. Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection. Aziz N, Nishanian P, Taylor JM, Mitsuyasu RT, Jacobson JM, Dezube BJ, Lederman MM, Detels R, Fahey JL. J Infect Dis; 1999 Apr; 179(4):843-8. PubMed ID: 10068579 [Abstract] [Full Text] [Related]
58. Effects of AM3 (Inmunoferon) on increased serum concentrations of interleukin-6 and tumour necrosis factor receptors I and II in cyclists. Cordova A, Monserrat J, Villa G, Reyes E, Soto MA. J Sports Sci; 2006 Jun; 24(6):565-73. PubMed ID: 16608770 [Abstract] [Full Text] [Related]
59. Antiarthritic activity of soluble tumor necrosis factor receptor type I forms in adjuvant arthritis: correlation of plasma levels with efficacy. McComb J, Gould T, Chlipala E, Sennelo G, Frazier J, Kieft G, Seely J, Edwards CK, Bendele A. J Rheumatol; 1999 Jun; 26(6):1347-51. PubMed ID: 10381054 [Abstract] [Full Text] [Related]
60. Soluble receptors for tumor necrosis factor: occurrence in association with normal delivery at term. Austgulen R, Johnsen H, Kjøllesdal AM, Liabakk NB, Espevik T. Obstet Gynecol; 1993 Sep; 82(3):343-7. PubMed ID: 8395036 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]